These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23103234)

  • 1. The effects of positive patient testimonials on PTSD treatment choice.
    Pruitt LD; Zoellner LA; Feeny NC; Caldwell D; Hanson R
    Behav Res Ther; 2012 Dec; 50(12):805-13. PubMed ID: 23103234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are PTSD treatment choices and treatment beliefs related to depression symptoms and depression-relevant treatment rationales?
    Rytwinski NK; Rosoff CB; Feeny NC; Zoellner LA
    Behav Res Ther; 2014 Oct; 61():96-104. PubMed ID: 25151916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of sertraline with prolonged exposure in the treatment of posttraumatic stress disorder.
    Rothbaum BO; Cahill SP; Foa EB; Davidson JR; Compton J; Connor KM; Astin MC; Hahn CG
    J Trauma Stress; 2006 Oct; 19(5):625-38. PubMed ID: 17075912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Examining PTSD treatment choice among individuals with subthreshold PTSD.
    Bergman HE; Kline AC; Feeny NC; Zoellner LA
    Behav Res Ther; 2015 Oct; 73():33-41. PubMed ID: 26246029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analog study of patient preferences for exposure versus alternative treatments for posttraumatic stress disorder.
    Becker CB; Darius E; Schaumberg K
    Behav Res Ther; 2007 Dec; 45(12):2861-73. PubMed ID: 17612502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What you believe is what you want: modeling PTSD-related treatment preferences for sertraline or prolonged exposure.
    Zoellner LA; Feeny NC; Bittinger JN
    J Behav Ther Exp Psychiatry; 2009 Sep; 40(3):455-67. PubMed ID: 19577224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating "types" of treatment dropout: Nonstarters in an RCT of prolonged exposure versus sertraline.
    Kline AC; Baier AL; Klein AB; Feeny NC; Zoellner LA
    Behav Res Ther; 2020 Dec; 135():103750. PubMed ID: 33035741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD.
    Zoellner LA; Roy-Byrne PP; Mavissakalian M; Feeny NC
    Am J Psychiatry; 2019 Apr; 176(4):287-296. PubMed ID: 30336702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "How will it help me?" Reasons underlying treatment preferences between sertraline and prolonged exposure in posttraumatic stress disorder.
    Chen JA; Keller SM; Zoellner LA; Feeny NC
    J Nerv Ment Dis; 2013 Aug; 201(8):691-7. PubMed ID: 23896851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual symptoms of PTSD following Sertraline plus enhanced medication management, Sertraline plus PE, and PE plus placebo.
    Tripp JC; Norman SB; Kim HM; Venners MR; Martis B; Simon NM; Stein MB; Allard CB; Rauch SAM;
    Psychiatry Res; 2020 Sep; 291():113279. PubMed ID: 32763541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "I need to talk about it": a qualitative analysis of trauma-exposed women's reasons for treatment choice.
    Angelo FN; Miller HE; Zoellner LA; Feeny NC
    Behav Ther; 2008 Mar; 39(1):13-21. PubMed ID: 18328866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of prolonged exposure and sertraline on emotion regulation in individuals with posttraumatic stress disorder.
    Jerud AB; Pruitt LD; Zoellner LA; Feeny NC
    Behav Res Ther; 2016 Feb; 77():62-7. PubMed ID: 26723004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial.
    Hien DA; Levin FR; Ruglass LM; López-Castro T; Papini S; Hu MC; Cohen LR; Herron A
    J Consult Clin Psychol; 2015 Apr; 83(2):359-69. PubMed ID: 25622199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What would you choose? Sertraline or prolonged exposure in community and PTSD treatment seeking women.
    Feeny NC; Zoellner LA; Mavissakalian MR; Roy-Byrne PP
    Depress Anxiety; 2009; 26(8):724-31. PubMed ID: 19544313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of Response to Prolonged Exposure, Sertraline, and Their Combination for the Treatment of Military PTSD.
    Rauch SAM; Kim HM; Lederman S; Sullivan G; Acierno R; Tuerk PW; Simon NM; Venners MR; Norman SB; Allard CB; Porter KE; Martis B; Bui E; Baker AW;
    J Clin Psychiatry; 2021 Jun; 82(4):. PubMed ID: 34133087
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of prolonged exposure therapy versus pharmacotherapy and treatment choice in posttraumatic stress disorder (the Optimizing PTSD Treatment Trial): a doubly randomized preference trial.
    Le QA; Doctor JN; Zoellner LA; Feeny NC
    J Clin Psychiatry; 2014 Mar; 75(3):222-30. PubMed ID: 24717377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaginal exposure exacerbation revisited: Deconstructing patient characteristics associated with worse reactions to the initiation of imaginal exposure in PTSD.
    Walker RSW; Marks EH; Jaeger J; Duax JM; Feeny NC; Zoellner LA
    Behav Res Ther; 2020 Dec; 135():103747. PubMed ID: 33049550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding factors associated with early therapeutic alliance in PTSD treatment: adherence, childhood sexual abuse history, and social support.
    Keller SM; Zoellner LA; Feeny NC
    J Consult Clin Psychol; 2010 Dec; 78(6):974-9. PubMed ID: 20873895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in temporal attention inhibition following prolonged exposure and sertraline in the treatment of PTSD.
    Echiverri-Cohen A; Zoellner LA; Gallop R; Feeny N; Jaeger J; Bedard-Gilligan M
    J Consult Clin Psychol; 2016 May; 84(5):415-26. PubMed ID: 26900894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Providing a treatment rationale for PTSD: does what we say matter?
    Feeny NC; Zoellner LA; Kahana SY
    Behav Res Ther; 2009 Sep; 47(9):752-60. PubMed ID: 19616197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.